Hint mode is switched on Switch off
For swift navigation between sections

Organization: Gilead Sciences
LEI 549300WTZWR07K8MNV44, Swift GILSUS6SXXX

Full name of organization
Gilead Sciences Inc
Country of risk
USA
Country of registration
USA
Industry
Healthсare
Credit ratings
in foreign currency
  • M/S&P/F
    -/***/-
Bond debt
29,500 mln USD
DATA PLATFORM FOR FINANCIAL MARKET PROFESSIONALS AND INVESTORS
  • High performance interface for global bond market screening
  • Full information on close to 400,000 bonds from 180 countries
  • 100% coverage of Eurobonds worldwide
  • Over 300 primary sources of prices
  • Ratings data from all international and local ratings agencies
  • Stock market data from 60 world trading floors
  • Intuitive, high speed user interface
  • Data access via the website, mobile application and add-in for Microsoft Excel

Latest data on

Profile

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company primary areas of focus include HIV, AIDS, liver disease, and
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company primary areas of focus include HIV, AIDS, liver disease, and serious cardiovascular and respiratory conditions.

Awards

Company analytics

{{ comment.date }}
All analytics

Latest issues

Documentation

Affiliates

Stocks

About company

Bond debt by currency

Codes

  • LEI
    549300WTZWR07K8MNV44
  • Swift
    GILSUS6SXXX
  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • CIK
    0000882095

Credit ratings

Indices by country